12 primer pairs and locked nucleic acid probes were designed to target the cps gene of 18 serotypes and were used in 3 multiplex and a simplex qPCR: serotypes 1, 3, 4, and 5 in multiplex S. pneumonia isolates, when available, were sent to Murdoch Children Research Institute.
Serotyping was performed by latex agglutination using a combination of commercial and inhouse typing reagents (19) , and results were confirmed using the Quellung reaction.
H. influenzae typing
Positive CSF or isolates, when available, were sent to Haemophilus Reference Laboratory in the United Kingdom (Respiratory and Vaccine Preventable Bacteria Reference Unit, Public Health England, Colindale) for H. influenzae typing by hydrolysis probe qPCR based on Maaroufi et al. (20) .
This consisted of a triplex hydrolysis probe qPCR for ompP2 (detection of all H. influenzae), bexA (to detect the capsule operon in any capsulated strains), and H. influenzae specific target (based on the H. influenzae type b [Hib] specific region of the capsule operon) using 12.5 μL of TaqMan universal master mix (Applied Biosystems, Thermo Fisher Scientific) and 1 μL of DNA. The oligonucleotide concentrations used were 900 nmol/L for ompP2 reverse primer and Hib forward and reverse primers, 300 nmol/L for ompP2 forward primer and bexA forward and reverse primers, 50 nmol/L for ompP2 probe, 500 nmol/L for bexA probe, and 250 nmol/L for Hib probe. The cycling parameters were 50°C for 2 min and 95°C for 10 min, followed by 40 cycles of 95°C for 15 sec and 58°C for 1 min.
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N. meningitidis typing DNA from positive samples for N. meningitidis were sent to Meningococcal Reference Unit, Health Protection Agency, Manchester, UK, for typing by hydrolysis probe qPCR assay based on Meningococcal Reference Unit and Corless et al. methods (17, 21) . Modification has been made as improvement of CtrA System and the use of freeze-dried Taqman Quadruplex assay (22) . The quadruplex contains primers against N. meningitides capsule transporter (ctrA), serogroup B sialyltransferase (siaDB), S. pneumoniae pneumolysin (ply), and an internal control (Cucurbita cv. Kurokawa amakuri hydroxypyruvate reductase). The assay was prepared by Applied Biosystems (Thermo Fisher Scientific) in a lyophilized format, with primer and probe sequences provided by the MRU; the components of the master mix have not been disclosed by the company. Lyophilized reagents were rehydrated with 20 μL of molecular-grade water, and then, 5 μL of DNA was added. Amplification and detection was done on TaqMan 7500 (Applied Biosystems, Thermo Fisher Scientific) using fast cycling conditions (2 min at 95°C, 45 cycles of 95°C for 3 sec and 60°C for 30 sec).
Orientia tsutsugamushi PCR
This hydrolysis probe qPCR was based on that described by Jiang et al. (23) targeting the 47-kD gene. In total, 1 µL of DNA extract from EDTA buffy coat and 5 µL for CSF was used in a 25-µL reaction with the Platinum Quantitative PCR SuperMix-UDG (Invitrogen) kit and 100 nmol/L of each primer and 200 nmol/L of probe. The thermal cycling program was 50°C for 2 min, 95°C for 2 min, and 45 cycles of 95°C for 15 sec and 60°C for 60 sec. All positive qPCRs were confirmed by sequencing (Macrogen Inc) or conventional PCR targeting 56 kDa as previously described (24) .
Rickettsia genus and Rickettsia typhi PCR
This assay is a hydrolysis probe qPCR targeting the 17-kDa gene of Rickettsia spp.
(23,25) using 1 µL of DNA extracted from the EDTA buffy coat and 5 µL for CSF, in a 25-µL reaction volume. The Platinum Quantitative PCR SuperMix-UDG kit (Invitrogen, Thermo Fisher Scientific) was used in a final volume of 25 μL, with 400 nmol/L of each primer and probe. The thermal cycling program was 50°C for 2 min, 95°C for 2 min, and 45 cycles of 95°C for 15 sec and 60°C for 30 sec.
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Rickettsia genus-positive samples were confirmed as Rickettsia typhi using a confirmatory hydrolysis probe qPCR, targeting ompB gene, as described by Henry et al. (26) . In total, 1 µL of buffy coat DNA and 5 µL of CSF DNA was used in a 25-µL reaction volume, with the Platinum Quantitative PCR SuperMix-UDG (Invitrogen, Thermo Fisher Scientific) and 400 nM of each primer and probe. The thermal cycling program was 50°C for 2 min, 95°C for 2 min, and 45 cycles of 95°C for 15 sec and 60°C for 30 sec. Repeatedly ompB-positive samples were processed for sequencing, following a conventional PCR targeting the 17-kDa gene, to identify the Rickettsia species. Conventional PCR was performed using Platinum Taq DNA polymerase (Invitrogen, Thermo Fisher Scientific), 300 nmol/L of each primer, forward 1 and reverse, 0.2 mmol/L of dNTPs, 2 mmol/L of MgCl2, 1 U of Taq, and 1 μL of DNA in a final volume of 25 μL. The thermal cycling program was 94°C for 1 min and 34 cycles of 94°C for 30 sec, 55°C for 30 sec, and 68°C for 2 min, ending with 72°C for 7 min. A nested PCR is performed using the same conditions as the first PCR, with the same reveres primer and forward 2 primer on 1 μL of the first PCR product. The PCR product of the nested PCR was sent to Macrogen Inc. (Seoul, South Korea) for purification and sequencing. Sequencing results were identified using NCBI nucleotide BLAST.
Viral PCR
Protocols for virus detection were transferred from Virology Laboratory at La Timone Hospital, Marseille, France, where they are used for routine diagnosis, to the microbiology laboratory of Mahosot Hospital.
Real-time PCRs for the detection of herpes simplex virus (HSV) 1 and 2 (27) , human cytomegalovirus (HCMV) (28) , varicella zoster virus (VZV) (29) , West Nile virus (WNV) (30) , Tick-borne encephalitis virus (TBEV) (31) , Enterovirus (EV) (32) , Dengue virus (33) , Henipavirus (in house system), panflavivirus (34, 35) , measles virus (36) , mumps virus (37) , and influenza viruses A and B (38) were performed on CSF and admission serum for all patients when available.
The HSV1/2 system permits to detect HSV1 and HSV2 viruses. Samples positive by HSV1/2 PCR were submitted to 2 specific hydrolysis probe qPCRs for the detection of HSV1 and HSV2 (39) . Detection of Dengue virus was done using a pan-dengue hydrolysis probe qPCR system designed to detect the 4 dengue serotypes. Positive samples were then submitted to the 4 Page 11 of 50 hydrolysis probe qPCRs specific for the 4 serotypes. The hydrolysis probe qPCR used for the detection of EV is a pan-EV system that permits detection of all enteroviruses. Typing of EVpositive samples was performed following techniques developed by Nix et al. (40) , see below, directly on patient sample extract or after inoculation on cell culture, when possible.
The primers and probe for detection of Henipavirus were designed using alignment of all Hendra and Nipah virus sequences available in GenBank.
PCR conditions were adapted to a standard 2-step protocol using TaqMan Reverse Transcription Reagents kit (Roche) for RNA viruses, followed by hydrolysis probe qPCR using 80 nmol/L of probe in a final volume of 50 µL. qPCRs were performed using Mx3000P QPCR System (Agilent Technologies, Santa Clara, CA USA) with standard thermal cycling (50°C for 2 min, 95°C for 10 min, and 45 cycles of 95°C for 15 sec and 60°C for 1 min). WNV and TBEV primers and probes were used in a duplex qPCR following the same protocol. Any samples positive with a cycle quantification (Cq) <40 were repeated for confirmation.
Internal controls (MS2 and T4, RNA and DNA bacteriophages, respectively) were added to all specimens and systematically tested by hydrolysis probe qPCR (14) . T4 and MS2 qPCRs were performed on 3 µL of DNA (RT product for MS2, nucleic acid extract for T4) in a final volume of 15 µL. In case of no detection of internal control, a new sample was extracted. In case of inhibition of the PCR, the extract sample was diluted 1:10 in AVE buffer (QIAGEN), and all qPCR reactions were repeated from this dilution. BLASTed on the NCBI Web site (blastn) for identification. All negative primary panflavivirus PCRs underwent a heminested PCR using 3 µL of the primary PCR product, the same reverse primer, the forward 2 primer, and the same amplification protocol as in the primary PCR.
Amplicons (162 bp) were sent for sequencing to Macrogen Inc. Then, the sequences were BLASTed (blastn, NCBI website) for identification.
Enterovirus typing
The typing of EV was performed using the protocol from the French reference center for Enterovirus based on Nix et al. (40) . When available, clinical samples EV-positive by RT-qPCR were inoculated on MRC5, BGM, and MA104 cells in 12-well plates. In cases of cytopathic effect, cell supernatant was collected, extracted using EZ1 Virus Mini Kit v2.0 (QIAGEN), and submitted to pan-EV hydrolysis probe RT-qPCR using SuperScript III Platinum One-Step qRT- The primary PCR with primers 1 produce a 990-bp amplicon. In case of negative primary PCR, a nested PCR was performed with 5 µL of the primary PCR product using 2.5 U of Nested PCR with primers 2 produce a 375-bp amplicon. Amplicons from primary or nested PCR were sent for sequencing to Macrogen Inc. Then, the sequences were BLASTed (blastn, NCBI website) for identification. 
*In September 2016 we reviewed articles published in English in the Medline database in the past 15 years using the terms "encephalitis," "meningitis," "CNS syndrome" "CNS infection" "central nervous system syndrome" "central nervous system infection," with adding the terms "asia," or "south-east asia. Occupation: work indoors = teacher, government official, business, factory worker, accountant; work outdoors = driver, building worker, merchant, carpenter, soldier, mechanic; other: housewife, no job, monk, retired, singer, health worker. History or physical examination were taken into account for: rash, confusion, neck stiffness, photophobia, fever (history of fever or >37.5°C during physical examination). ‡Antibiotics used before LP were: Ceftriaxone (47%), Ampicilin (17.5%), Gentamycin (11.5%), Doxycycline (8.0%), Amoxicillin (6.6%), Cefotaxime (5.9%), Penicillin (5.6%), Chloramphenicol (3.4%), Co-trimoxazole (3.1%), Ofloxacin (2.7%), Erythromicin (2.2%), Cloxacillin (1.7%), Metronidazole (1.4%), Co-amoxiclav (1.2%), Ceftazidime (0.5%), Anti tuberculosis (0.8%), Quinine (0.5%), Cefalexin (0.3%), Tetracycline (0.2%). §Data collected for children (<15 years old) were excluded for analysis. ⁋Considered as not reliable, the data were excluded from analysis for children <3 y old. #Of these patients, 7 had hemiplegia, 11 had limb weakness, and 1 had paraplegia; 13 patients had admission or discharge diagnoses of GuillainBarre syndrome. Retrospective evaluation of the likelihood of this diagnosis by using the Brighton system suggested that 4 patients met level 3 criteria for Guillain-Barre syndrome diagnostic certainty (Sejvar et al. 2011). **Including confused and disoriented. † †WHO clinical CNS infection = fever with either GCS score <15, neck stiffness (history or examination), or history of seizure, patients with missing data for one of those criteria were not counted. WHO encephalitis = fever with either GCS score <15 or history of seizure. WHO meningitis = fever with GCS score <15 and/or neck stiffness. WHO meningoencephalitis = meeting both WHO encephalitis and WHO meningitis criteria. ‡ ‡Elevated and low parameters = above or below normal ranges (Appendix Table 3 ), anemia: hematocrit below normal range. In elevated CSF white cells count, were not taken into account the cases that could not be counted because of high turbidity. Eosinophilia = CSF eosinophils >10%. § §Elevated serum sodium: higher than 150 mmol/L, low serum sodium: lower than <130 mmol/L. Five patients (0.6%) had serum sodium <115 mmol/L.
⁋ ⁋Hyperglycemia = blood glucose higher than 7.7 mmol/L, severe hyperglycemia: blood glucose higher than 11.1 mmol/L. ##Mortality includes patients who died at hospital and the ones who were taken to die at home = moribund.
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Appendix Table 3 , consisting of direct detection of the pathogen in CSF or serum or IgM detection in CSF, or antibody seroconversion between admission and follow-up serum. Based on Phommasone et al. (54) , when >1 pathogen was detected in1 patient, the confirmed etiology was determined by giving the priority to direct detection over indirect detection and to CSF over blood. Confirmed co-infection was defined when >1 pathogens were detected in the same site (CSF or blood), both by direct tests, or both by indirect tests. Ag, antigen; CSF, cerebrospinal fluid; HCMV, human cytomegalovirus; HSV, herpes simplex virus; JEV, Japanese encephalitis virus; NS1, nonstructural protein 1; VZV, varicella zoster virus. Table 5 . Confirmed etiology was determined according to positive results by the tests presented in Table 3 , consisting in direct detection of the pathogen in CSF or blood, IgM detection in CSF, antibody seroconversion or 4-fold rise in antibody titter between admission and follow-up serum. When >1 pathogens were detected in a same patient, the confirmed etiology was determined by giving the priority to direct detection over indirect detection then to CSF over blood. Confirmed co-infection was defined when > one pathogens were detected by the same kind of test in the same matrix. List of confirmed coinfections in supplemental data (Appendix Table 4 ). The other etiologies confirmed in <20 patients were cytomegalovirus in 12 patients, herpes simplex virus in 15, Enterovirus in 10, varicella zoster virus in 6, mumps virus in 5, Plasmodium falciparum in 4, and other bacteria in 48 patients (the list of bacteria is provided in Appendix Table 5 ). Among 35 patients with CSF eosinophils >10%, 4 were found positive for Angiostrongylus cantonensis by PCR (55) . Among 662 patients tested for syphilis by the SD. Bioline RDT (Cat No. 06FK10) on serum then confirmed by VDRL and TPHA on serum and CSF, 2 patients could be classified as possible neurosyphilis, as per the UK and European guidelines (TPHA positive in CSF). Other bacterial antibiotic susceptibility data are given in Appendix Table 6 . Typing information for Cryptococcus spp. is presented in Appendix Table 5 . ALP, alkaline phosphatase; ALT, alanine transaminase; AST, aspartate transaminase; CNS, central nervous system; CRP, C-reactive protein; CSF, cerebrospinal fluid; GCS, Glasgow coma scale; IQR, interquartile range; JEV, Japanese encephalitis virus; LP, lumbar puncture; TB, M. tuberculosis; WHO, world health organization. †Nine Mycobacterium tuberculosis were sensitive to isoniazid (0.1 µg/mL, 0.4 µg/mL for one), rifampin (1.0 µg/mL), streptomycin (1.0 µg/mL), ethambutol (5.0 µg/mL), and pyrazinamide (100.0 µg/mL). Two were sensitive to rifampin (1.0 µg/mL), ethambutol (5.0 µg/mL), and pyrazinamide (100.0 µg/mL) and resistant to isoniazid (0.4 µg/mL) and streptomycin (1.0 µg/mL). Three were sensitive to isoniazid (0.1 µg/mL), rifampin (1.0 µg/mL), ethambutol (5.0 µg/mL), and pyrazinamide (100.0 µg/mL) and resistant to streptomycin (1.0 µg/mL). For 1 patient only the test for isoniazid and rifampin could be performed, M. tuberculosis was sensitive for both. Susceptibility testing could not be performed for 4 patients. ‡Population density of the village of residence: Population densities per village were from population census 2005, recovered from Lao DECIDE info Web site (platform of Government of Lao PDR, www.decide.la). §Occupation classification: work indoors = teacher, government official, business, factory worker, accountant; work outdoors = driver, building worker, merchant, carpenter, soldier, mechanic; other = housewife, no job, monk, retired, singer, health worker. ¶Data collected for children (<15 y old) were excluded for analysis. #Considered as not reliable, the data were excluded from analysis for children <3 years old. **Including confused and disoriented. † †WHO clinical CNS infection= fever with either GCS score <15, neck stiffness (history or examination), or history of seizure, patients with missing data for 1 of those criteria were not counted. WHO encephalitis = fever with GCS score <15 or history of seizure or both. WHO meningitis = fever with GCS score <15 or neck stiffness or both. WHO meningoencephalitis = meeting both WHO encephalitis and WHO meningitis criteria. ‡ ‡Elevated and decreased parameters = above or below normal ranges (Appendix Table 3 ), anemia: hematocrit below normal range. In elevated CSF white cell count, were not taken into account the cases that could not be counted because of high turbidity.
Appendix
§ §Hyperglycemia: blood glucose higher than 7.7 mmol/L, severe hyperglycemia: blood glucose higher than 11.1 mmol/L. ¶ ¶CSF eosinophils >10%. Univariate analyses were performed to compare patients with confirmed bacterial infection (175, including patients with bacterial co-infection) to other patients (875, excluding patients with coinfection involving bacteria and virus or Cryptococcus). History or physical examination were taken into account for rash, confusion, neck stiffness, fever (history of fever or >37.5°C during physical examination). ALP, alkaline phosphatase; ALT, alanine transaminase; AST, aspartate transaminase; CRP, C-reactive protein; CNS, central nervous system; CSF, cerebrospinal fluid; GCS, Glasgow coma scale; IQR, interquartile range; LP, lumbar puncture; TB, Mycobacterium tuberculosis; WHO, World Health Organization. †Population density of the village of residence: Population densities per village were from population census 2005, recovered from Lao DECIDE info Web site (platform of Government of Lao PDR, www.decide.la). ‡Occupation: work indoors = teacher, government official, business, factory worker, accountant; work outdoors = driver, building worker, merchant, carpenter, soldier, mechanic; other: housewife, no job, monk, retired, singer, health worker. §Data collected for children (<15 years old) were excluded for analysis. ¶Considered as not reliable, the data were excluded from analysis for children <3 years old. #Including confused and disoriented. **WHO clinical CNS infection = fever with either GCS score <15, neck stiffness (history or examination), or history of seizure, patients with missing data for 1 of those criteria were not counted. WHO encephalitis = fever with GCS score <15 or history of seizure or both. WHO meningitis = fever with GCS score <15 or neck stiffness or both. WHO meningoencephalitis = meeting both WHO encephalitis and WHO meningitis criteria. † †Elevated and low parameters = above or below normal ranges (Appendix Table 3 ), anemia: hematocrit below normal range. In elevated CSF white cell count, were not taken into account the cases that could not be counted because of high turbidity.
‡ ‡Hyperglycemia: blood glucose higher than 7.7 mmol/L, severe hyperglycemia: blood glucose higher than 11.1 mmol/L. § §Eosinophilia: CSF eosinophils >10%. *The factors that showed p<0.01 in univariate analysis were submitted to multivariate analysis. Some factors were excluded (e.g., HIV seropositivity), since the choice for patient testing was biased. Clinical meningitis was correlated with neck stiffness, neutrophils was correlated with white cell count, and hyperglycemia was correlated with diabetes (a model was run replacing diabetes with hyperglycemia or blood glucose, which turned out to be not significant). aOR, adjusted odds ratio; CSF, cerebrospinal fluid; MICE, multiple imputation by chained equation. †Complete case analysis was repeated with only significant factors (p<0.05) identified by stepwise approach (n = 607). ‡Final model with imputed values with only significant variables included (n = 1,043). §Variables with imputed values. Other variables included in the imputation model: bacterial infection (outcome), sex, age, fever, and neck stiffness. ¶The aOR for a 10-U increase in C-reactive protein or CSF lactate. §Data collected for children (<15 years old) were excluded for analysis. ¶Considered as not reliable, the data were excluded from analysis for children <3 y old. #Including confused and disoriented. **WHO clinical CNS infection: fever with either GCS score<15, neck stiffness (history or examination), or history of seizure, patients with missing data for 1 of those criteria were not counted. WHO encephalitis = fever with GCS score <15 or history of seizure or both. WHO meningitis = fever with GCS score <15 or neck stiffness or both. WHO meningoencephalitis = meeting both WHO encephalitis and WHO meningitis criteria. † †Elevated and low parameters = above or below normal ranges (Appendix Table 3 ), anemia: hematocrit below normal range. In elevated CSF white cell count, were not taken into account the cases that could not be counted because of high turbidity.

‡ ‡Hyperglycemia: blood glucose higher than 7.7 mmol/L, severe hyperglycemia: blood glucose higher than 11.1 mmol/L. § §Eosinophilia: CSF eosinophils >10%. *In the table are reported number of patients (percentage). Syndromic classification was done only for patients with data available for all criteria: fever (history of fever or >37.5°C during physical examination), neck stiffness (history or examination), GCS score and history of seizure = 1,040 patients. Among the 25 patients with missing data, 1 was confirmed for S. pneumoniae, 1 for Streptococcus agalactiae, 1 for Cryptococcus spp.1 for Dengue virus, 1 for HCMV, 1 for HSV1/2, 1 for VZV. Fever = history of fever or documented fever (>37.5°C), neck stiffness = history or at examination, Seizures = history of seizures, GCS score <15 = GCS score total <15 and when GCS score total is missing = confused or disoriented. CNS, central nervous system; GCS, Glasgow coma scale; HCMV, human cytomegalovirus; HSV, herpes simplex virus; JEV, Japanese encephalitis virus; VZV, varicella zoster virus. †No CNS infection = patients who don't meet criteria for World Health Organization clinical CNS infection (fever with either GCS score<15, neck stiffness, or history of seizures). ‡Occupation: work indoors = teacher, government official, business, factory worker, accountant; work outdoors = driver, building worker, merchant, carpenter, soldier, mechanic; other: housewife, no job, monk, retired, singer, health worker. §Data collected for children (<15 years old) were excluded for analysis. ¶Considered as not reliable, the data were excluded from analysis for children <3 y old. #Including confused and disoriented. **WHO clinical CNS infection: fever with either GCS score <15, neck stiffness (history or examination), or history of seizure, patients with missing data for 1 of those criteria were not counted. WHO encephalitis = fever with GCS score<15 or history of seizure or both. WHO meningitis = fever with GCS score <15 or neck stiffness or both. WHO meningoencephalitis = meeting both WHO encephalitis and WHO meningitis criteria. † †Elevated and low parameters = above or below normal ranges (Appendix Table 3 ), anemia: hematocrit below normal range. In elevated CSF white cell count, were not taken into account the cases that could not be counted because of high turbidity.
‡ ‡Hyperglycemia: blood glucose higher than 7.7 mmol/L, severe hyperglycemia: blood glucose higher than 11.1 mmol/L. § §Eosinophilia: CSF eosinophils >10%. *GCS score <15 = GCS score total <15 and when GCS score total is missing = confused or disoriented CRP, C-reactive protein; CSF, cerebrospinal fluid; GCS, Glasgow coma scale; WCC, white cell count. †Neck stiffness: history or examination.
